Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.

Liu H, Zhang W, Xu Z, Caldwell RW, Caldwell RB, Brooks SE.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):918-31. doi: 10.1167/iovs.12-11291.

2.

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.

Zhang W, Yokota H, Xu Z, Narayanan SP, Yancey L, Yoshida A, Marcus DM, Caldwell RW, Caldwell RB, Brooks SE.

Invest Ophthalmol Vis Sci. 2011 Aug 11;52(9):6384-95. doi: 10.1167/iovs.11-7666.

3.

Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.

Gu L, Chen H, Tuo J, Gao X, Chen L.

Exp Eye Res. 2010 Sep;91(3):433-9. doi: 10.1016/j.exer.2010.06.019. Epub 2010 Jul 1.

PMID:
20599960
4.

Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.

Lutty GA, McLeod DS, Bhutto I, Wiegand SJ.

Invest Ophthalmol Vis Sci. 2011 Jun 8;52(7):4039-47. doi: 10.1167/iovs.10-6798.

5.

Suppression of retinal neovascularization by the iNOS inhibitor aminoguanidine in mice of oxygen-induced retinopathy.

Zhang Q, Zhang J, Guan Y, Zhang S, Zhu C, Xu GT, Wang L.

Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):919-27. doi: 10.1007/s00417-009-1066-x. Epub 2009 Mar 20.

PMID:
19301028
7.

The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.

Leske DA, Wu J, Fautsch MP, Karger RA, Berdahl JP, Lanier WL, Holmes JM.

Mol Vis. 2004 Jan 21;10:43-50.

8.

Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.

Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR.

Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2175-82.

PMID:
15914639
9.

Captopril and vascular endothelial growth factor in a mouse model of retinopathy.

Higgins RD, Yan Y, Geng Y, Sharma J, Barr SM.

Curr Eye Res. 2003 Aug;27(2):123-9.

PMID:
14632165
10.

The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.

Leske DA, Wu J, Mookadam M, Chen Y, Fautsch MP, Holmes JM, Lanier WL.

Curr Eye Res. 2006 Feb;31(2):163-9.

PMID:
16500767
11.

Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.

van Wijngaarden P, Brereton HM, Gibbins IL, Coster DJ, Williams KA.

Exp Eye Res. 2007 Oct;85(4):508-17. Epub 2007 Jul 10.

PMID:
17692314
12.

Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP.

Budd S, Byfield G, Martiniuk D, Geisen P, Hartnett ME.

Exp Eye Res. 2009 Nov;89(5):718-27. doi: 10.1016/j.exer.2009.06.011. Epub 2009 Jul 1.

14.

Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.

Jiang J, Xia XB, Xu HZ, Xiong Y, Song WT, Xiong SQ, Li Y.

J Cell Physiol. 2009 Jan;218(1):66-74. doi: 10.1002/jcp.21566.

PMID:
18767037
15.

RPE cells modulate subretinal neovascularization, but do not cause regression in mice with sustained expression of VEGF.

Ida H, Tobe T, Nambu H, Matsumura M, Uyama M, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5430-7.

PMID:
14638748
16.

Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

Davies MH, Zamora DO, Smith JR, Powers MR.

Microvasc Res. 2009 May;77(3):382-6. doi: 10.1016/j.mvr.2009.01.013. Epub 2009 Feb 13.

17.
18.

Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.

Nambu H, Umeda N, Kachi S, Oshima Y, Akiyama H, Nambu R, Campochiaro PA.

J Cell Physiol. 2005 Jul;204(1):227-35.

PMID:
15648096
19.

Ephrin-a4 is involved in retinal neovascularization by regulating the VEGF signaling pathway.

Du W, Yu W, Huang L, Zhao M, Li X.

Invest Ophthalmol Vis Sci. 2012 Apr 18;53(4):1990-8. doi: 10.1167/iovs.11-8788.

PMID:
22408005
20.

Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.

Wakusawa R, Abe T, Sato H, Sonoda H, Sato M, Mitsuda Y, Takakura T, Fukushima T, Onami H, Nagai N, Ishikawa Y, Nishida K, Sato Y.

Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3272-80. doi: 10.1167/iovs.10-6295.

PMID:
21345982
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk